20746-full
doughntpanic
Sex: F
Data Quality: 2 stars
MS: 13 yrs
Type: Relapsing-Remitting
Relapse: Moderate
Sensation: Moderate
Overall: Mild
Cognition: moderate
Vision: moderate
Speech: mild
Swallowing: mild
Upper limb: moderate
Walking: moderate
doughntpanic
Female, 50 years
CA, United States
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

doughntpanic's Copaxone is for:

  • MS

doughntpanic has not reported any side effects for Copaxone.

doughntpanic's Copaxone History (Ongoing)
Copaxone (glatiramer acetate)
20 mg Daily May 28, 2010 - Last Update
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Jun 18, 2011 20 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default NoneNoneNoneNone UsuallyUsuallyUsuallyUsually A littleA littleA littleA little
Feb 13, 2011 20 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default NoneNoneNoneNone AlwaysAlwaysAlwaysAlways A littleA littleA littleA little
Aug 03, 2010 20 mg Daily ? MildMildMildMild AlwaysAlwaysAlwaysAlways A littleA littleA littleA little
Date
Feb 13, 2011
Advice & Tips
I inject my copaxone every evening before bed after my shower. I have found that if I inject slowly I have much less trouble with pain & lumps after the injection. The stinging, pain & itch has decreased over time as I have been on Copaxone for over 8 months. You are not supposed to massage the site for 24 hours after injecting but it helps to do so if it has been >24hrs. I will never be able to know for sure but I believe this treatment has been very effective. I have been doing much better after several months on it.
Cost
$25-49 monthly

About Copaxone (Prescription Drug)

Copaxone®, a brand name of glatiramer acetate, combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection. Read more...Click to read more below

Learn more about Copaxone in our Copaxone Community Report.